COVIDFAST
associated with 4 other trademarks
Screening kits for direct analysis of pathogen nucleic acid in a body fluid sample without prior nucleic acid extraction Extraction-free amplification...

Words that describe this trademark:

body fluid  screening kits  direct analysis  nucleic acid  acid body  kits direct  fluid sample  analysis  sample  pathogen 

Serial Number:

97337655

Mark:

COVIDFAST

Status:

Abandoned-Failure to Respond

Status Date:

10-03-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Screening kits for direct analysis of pathogen nucleic acid in a body fluid sample without prior nucleic acid extraction Extraction-free amplification and analysis of pathogen nucleic acid, including bacteria and viruses; medical diagnostic testing, monitoring, and reporting services Medical diagnostic and screening kits for direct analysis of pathogen nucleic acid in a body fluid sample without prior nucleic acid extraction

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

Standart Character Mark

Abandon Date:

07-17-2023

Business Name:

WITHERS BERGMAN LLP

Correspondent Name:

Recent Trademark filings by this company